Stay updated on Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Sign up to get notified when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.

Latest updates to the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 added; earlier notices about government funding status and the v3.4.1 revision were removed.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding and NIH operations, and updated the record to Revision v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check28 days agoChange DetectedUI improvements on the Record History page add a glossary display option and color-coded highlights for changes (green for additions, red for deletions). The page also updates revision notes to v3.4.0, replacing the previous v3.3.4.SummaryDifference1%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed in the record history, reflecting routine page maintenance with no changes to trial content or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 now appears in the page footer, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check91 days agoChange DetectedA new revision, v3.3.2, has been added to the study's history, and the previous revision v3.2.0 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Anti-CTLA-4 vs Degarelix in Prostate Cancer page.